Curaleaf New Jersey on Friday said it has released the first cannabis strain-specific vape concentrate available in New Jersey.
The Bellmawr-based Alternative Treatment Center had to obtain state approval to release the new product.
Vape cartridges are available in lavender, strawberry cough and cookies strains.
“Receiving approval to launch these products is an important milestone in the progression of Curaleaf’s operations as well as in New Jersey’s medical cannabis program,” said George Schidlovsky, president of Curaleaf New Jersey, in a statement. “As the largest dispensary on the East Coast serving hundreds of patients daily, Curaleaf has the resources and production capacity to reliably market and distribute new products that our patients depend on to live life well.”
According to Curaleaf, each cartridge is tested to guarantee a uniform quantity of Tetrahydrocannabinol (THC) and/or Cannabidiol (CBD) for a consistent patient experience. The ATC’s Twitter page highlights 70 percent THC cartridges now available for purchase.
“These concentrates, which surpass the state’s high standards of quality, provide an alternative method of administration for patients who may not be able to benefit from topical or oral forms of medical cannabis,” Schidlovsky said, adding vaping cannabis concentrate is considered a healthier alternative to smoking.
Curaleaf operates 28 dispensaries, 12 cultivation sites and nine processing sites in 12 states.